Karger Publishers, a global provider of scientific and medical content, has collaborated with Molecular Connections to implement Manuscript Insight™. The platform is a bespoke analytics and insights tool that offers publishers a comprehensive view of rejected manuscripts with its user-friendly visualization dashboards.
Manuscript Insight provides Karger Publishers with deeper perspectives into publishing trends, potential revenue loss, and key competitor journals that accept manuscripts rejected by the publisher. Molecular Connections proudly touts the platform’s accuracy rate at 99.99%, opening new possibilities for Karger to investigate missed opportunities and develop data-driven publishing strategies.
Additionally, the platform’s ability to identify instances of “cascading” – where a manuscript rejected by one journal within a publisher’s portfolio is accepted by another—enables Karger to create far more effective journal strategies.
“Manuscript Insight’s versatile features are truly convincing. We very much appreciated Molecular Connections’ work on further customizing the platform to meet our analytics requirements. With a diverse portfolio of over a hundred journals, we are eager to dive deep into the actionable insights and growth opportunities Manuscript Insight will provide,” said Mr. Daniel Ebneter, CEO of Karger Publishers.
“Manuscript Insight enables publishers to understand the competitive landscape, identify missed opportunities, and refine their journal strategies for better market positioning. It will support Karger’s business decisions and improve its editorial efficiency”, said Mr. Jignesh Bhate, CEO of MC, about the strategic alliance.
About Karger Publishers:
Connecting people and science since 1890, Karger provides scientists, healthcare professionals, patients, and the broader public with reliable and tailored information in Health Sciences. Building upon a publishing portfolio of more than 100 reputable scholarly journals and the award-winning Fast Facts medical info series, Karger excels in medical education and omnichannel HCP engagement in multiple formats, including 3D animations, podcasts, AR/VR environments, and more. Academic institutions and both medical affairs and pharma marketing teams in the corporate space entrust Karger with their most demanding communication challenges. Independent and family-led in the fourth generation by Chairwoman Gabriella Karger, Switzerland-based Karger is present in 15 countries with a team of 200 dedicated professionals worldwide.
About Molecular Connections:
With over two decades of expertise, Molecular Connections is at the forefront of AI-driven innovation in scholarly publishing. The company specializes in developing proprietary machine-learning models, knowledge graphs, and semantic technologies that drive digital transformation in the academic sphere. Recognized for its commitment to diversity, Molecular Connections boasts a workforce of over 70% women and is one of the top 15 employers for women in India.
With a workforce comprising over 70% women, Molecular Connections is among the top 15 preferred workplaces for women in India.
